-+ 0.00%
-+ 0.00%
-+ 0.00%
ProKidney Hosts KOL Event to Review Rilparencel Mechanism of Action Data
Share
Listen to the news
ProKidney Hosts KOL Event to Review Rilparencel Mechanism of Action Data
  • ProKidney will host a virtual key opinion leader event on October 27, 2026, at 10:30 a.m. ET.
  • Discussion will cover rilparencel's mechanism of action and potential role in advanced chronic kidney disease with type 2 diabetes.
  • Nephrologist Katherine Tuttle will provide clinical perspectives; management will deliver a corporate update.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220845PRIMZONEFULLFEED9851179) on October 22, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending